Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Medical Genetics

Building Your Care Team and Family Planning for ATS

At a Glance

ATS needs coordinated care from specialists familiar with inherited aortic disease, including genetics and cardiology, with other experts added for vascular, eye, lung, or neurologic concerns. Genetic counseling explains testing and pregnancy risks because ATS is autosomal recessive.

Managing Arterial Tortuosity Syndrome (ATS) is not a solo effort. Because the condition affects so many different parts of the body, it requires a “medical home” where multiple specialists work together. This team should ideally be based at a specialized center with deep experience in inherited aortopathies (conditions affecting the aorta) or rare connective tissue disorders [1][2].

Building Your Multidisciplinary Team

A comprehensive care team for ATS should include the following specialists, each focusing on a different aspect of the condition:

  • Medical Geneticists: These experts coordinate the molecular testing needed to confirm the SLC2A10 mutations. They also help the family understand inheritance patterns and risks for other family members [3][4].
  • Cardiologists (Pediatric or Adult): The cardiologist is often the “lead” on the team, performing serial echocardiograms and coordinating cross-sectional imaging (MRA or CTA) to track the aortic root and pulmonary arteries [2][5].
  • Vascular Surgeons and Interventionalists: These specialists evaluate and treat severe narrowing (stenosis) or bulging (aneurysm) of the vessels [6][7].
  • Ophthalmologists: Because ATS can cause significant eye issues like keratoconus or corneal thinning, a baseline ophthalmic assessment is appropriate, with follow-up intervals set by the eye specialist [8][9].
  • Pulmonologists: A lung specialist is vital if the twisted arteries are pressing against the airways or if there is high blood pressure in the lungs (pulmonary hypertension) [10][11].
  • Neurologists: A neurology consultation is important if there is a history of transient ischemic attacks (TIAs) or if imaging shows significant twisting of the arteries supplying the brain [12].

Genetics and Family Planning

ATS is an autosomal-recessive disorder. This means that a person with ATS inherited one pathogenic variant of the SLC2A10 gene from each parent [3][13].

  • Recurrence Risk (Carrier Parents): If both parents are confirmed carriers of the mutation, each of their future pregnancies has a 25% chance of having ATS, a 50% chance of being a carrier, and a 25% chance of inheriting neither familial variant [3][14].
  • Recurrence Risk (Adult with ATS): If an adult with ATS has a child, the reproductive risk depends entirely on the partner’s SLC2A10 status.
  • Cascade Testing: Once a diagnosis is confirmed, “cascade testing” is recommended for at-risk relatives using the known familial variants. This involves testing siblings to see if they are carriers [4][13].
  • Genetic Counseling: Families are strongly encouraged to meet with a genetic counselor. They can discuss reproductive options, such as preimplantation genetic testing (PGT) or prenatal diagnosis [3][14].

Prenatal Screening and Early Detection

With advances in imaging, it is sometimes possible to see clues of ATS before a baby is born.

  • Antenatal Clues: A specialized prenatal ultrasound or fetal echocardiogram may show unusual elongation or “twisting” of the great arteries. However, ultrasound findings are nonspecific clues and are not a reliable way to diagnose or rule out ATS [3][14]. Definitive testing requires molecular analysis.
  • A Call for Specialization: If ATS is suspected prenatally, the baby should be scheduled for delivery at a high-level medical center. This ensures that a specialized team—including neonatal cardiology and respiratory support—is ready to evaluate the newborn immediately after birth [3][14].

Vetting Your Doctors

When meeting with a new specialist, it is helpful to ask specific questions to gauge their familiarity with rare vascular conditions:

  • “How many patients with inherited aortopathies (like Marfan or Loeys-Dietz) do you currently manage?”
  • “Are you familiar with the specific vascular kinking and airway compression risks associated with ATS?”
  • “Does this hospital have a multidisciplinary board or clinic where different specialists discuss complex cases?”
  • “What is your protocol for coordinating care with my other specialists?” [1][15].

By surrounding yourself with an informed and communicative team, you can ensure that monitoring is thorough and that any changes in health are addressed quickly and expertly.

Common questions in this guide

What kind of doctors should be part of an ATS care team?
Care commonly includes a cardiologist and medical geneticist, with vascular surgery, ophthalmology, pulmonology, and neurology added according to the person’s blood-vessel, eye, lung, or neurologic findings. A specialized center can help these clinicians coordinate imaging, genetic testing, and follow-up.
What does ATS inheritance mean if both parents are carriers?
When both parents carry a pathogenic SLC2A10 variant, each pregnancy has a 25% chance of ATS, a 50% chance of being a carrier, and a 25% chance of inheriting neither familial variant. These percentages apply independently to each pregnancy.
How can an adult with ATS plan for a pregnancy?
The chance of having a child with ATS depends on whether the partner carries a pathogenic SLC2A10 variant. A genetic counselor can review the couple’s results and discuss options such as preimplantation genetic testing or prenatal diagnosis, with maternal-fetal medicine involved when appropriate.
Should relatives be tested after an ATS diagnosis?
At-risk relatives, especially siblings, may benefit from cascade testing for the known familial SLC2A10 variants. A genetic counselor can explain who should be tested and what a carrier or affected result means.
Can ATS be detected before birth?
A specialized prenatal ultrasound or fetal echocardiogram may show elongated or twisted great arteries, but these findings are not specific enough to confirm or exclude ATS. Molecular testing is needed for a definitive diagnosis, and suspected cases should be planned for delivery at a center prepared for specialized newborn heart and breathing support.
Why should ATS care be managed at a specialized center?
A center experienced with inherited aortic and connective tissue conditions can coordinate repeated heart imaging, blood-vessel evaluation, genetic care, and referrals to other specialists. This shared approach helps the team recognize and respond to changes in the heart, blood vessels, eyes, lungs, or nervous system.

Get notified when new evidence is published on Arterial tortuosity syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Arterial tortuosity syndrome: 40 new families and literature review.

    Beyens A, Albuisson J, Boel A, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2018; (20(10)):1236-1245 doi:10.1038/gim.2017.253.

    PMID: 29323665
  2. 2

    Arterial Tortuosity Syndrome: A Longitudinal Assessment of Cardiovascular Features and Interventions From the Collaborative for Longitudinal Aortic Research in the Young (CLARITY).

    Salamat B, Stephens SB, Britt JJ, et al.

    American journal of medical genetics. Part A 2025; (197(11)):e64159 doi:10.1002/ajmg.a.64159.

    PMID: 40613586
  3. 3

    Two fetuses in one family of arterial tortuosity syndrome: prenatal ultrasound diagnosis.

    Liang M, Wen H, Li S

    BMC pregnancy and childbirth 2021; (21(1)):548 doi:10.1186/s12884-021-03960-w.

    PMID: 34384376
  4. 4

    Arterial Tortuosity Syndrome in a Newborn: A Case Report With Literature Review.

    Al-Blushi S, Bantan NAA, Al-Abdullatif S, Taher MM

    Cureus 2022; (14(12)):e32899 doi:10.7759/cureus.32899.

    PMID: 36578839
  5. 5

    Case series: Arterial tortuosity syndrome confirmed by homozygous SLC2A10 variants.

    AlBathi A, AlHariqi BA, Rashid T, et al.

    Radiology case reports 2026; (21(8)):3504-3510 doi:10.1016/j.radcr.2026.05.005.

    PMID: 42253865
  6. 6

    Late Outcomes After Pulmonary Arterial Reconstruction in Patients With Arterial Tortuosity Syndrome.

    Al-Khaldi A, Momenah T, Alsahari A, et al.

    The Annals of thoracic surgery 2022; (113(5)):1569-1574 doi:10.1016/j.athoracsur.2021.03.063.

    PMID: 33811889
  7. 7

    Anesthetic Management of a Patient With Arterial Tortuosity Syndrome Undergoing Cerebral Revascularization Surgery-A Case Report.

    Ajayan N, Hrishi AP, Kumar A, Sethuraman M

    A&A practice 2022; (16(6)):e01593 doi:10.1213/XAA.0000000000001593.

    PMID: 35679159
  8. 8

    Ophthalmic Manifestations of Arterial Tortuosity Syndrome: Case Series of Patient and Carriers.

    Alharbi SS, Algorinees RM, Alshehri MA

    Cornea 2023; (42(4)):476-481 doi:10.1097/ICO.0000000000003226.

    PMID: 36728218
  9. 9

    Ophthalmic findings in patients with arterial tortuosity syndrome and carriers: A case series.

    Hardin JS, Zarate YA, Callewaert B, et al.

    Ophthalmic genetics 2018; (39(1)):29-34 doi:10.1080/13816810.2017.1335332.

    PMID: 28726533
  10. 10

    Arterial tortuosity syndrome presenting as severe precapillary pulmonary hypertension in adulthood.

    Baltodano Dangla CR, Romero Ríos CK, Urbina Maliaños CJ, et al.

    International journal of cardiology. Congenital heart disease 2026; (25()):100683 doi:10.1016/j.ijcchd.2026.100683.

    PMID: 42293359
  11. 11

    A Severe Form of Arterial Tortuosity Syndrome Presenting With Significant Airway Obstruction in an Infant.

    Dodge-Khatami J, Simpson SA, Dodge-Khatami A

    World journal for pediatric & congenital heart surgery 2020; (11(2)):238-240 doi:10.1177/2150135119829009.

    PMID: 31088211
  12. 12

    Arterial tortuosity syndrome causing recurrent transient ischemic attacks in young adult: a case report.

    Cotti Piccinelli S, Premi E, Bonacina S, et al.

    BMC neurology 2021; (21(1)):464 doi:10.1186/s12883-021-02458-4.

    PMID: 34847858
  13. 13

    Arterial tortuosity syndrome: Phenotypic features and cardiovascular manifestations in 4 newly identified patients.

    Esmel-Vilomara R, Valenzuela I, Riaza L, et al.

    European journal of medical genetics 2023; (66(9)):104823 doi:10.1016/j.ejmg.2023.104823.

    PMID: 37619836
  14. 14

    A Rare Case of Dichorionic Twins Concordant for Arterial Tortuosity Syndrome: Case Report and Review of the Literature.

    Ponziani I, Checcucci C, Masini G, Pasquini L

    Fetal diagnosis and therapy 2025; (52(4)):371-376 doi:10.1159/000543596.

    PMID: 39827853
  15. 15

    Arterial Tortuosity Syndrome: Unraveling a Rare Vascular Disorder.

    Ekhator C, Devi M, Barker C, et al.

    Cureus 2023; (15(9)):e44906 doi:10.7759/cureus.44906.

    PMID: 37692180

This page is for informational purposes only and does not constitute medical advice about Arterial Tortuosity Syndrome. Your genetics professional and treating specialists can help interpret SLC2A10 results and guide care and family-planning decisions.